Bukwang Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 25, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	528,843	314,207	417,573	598,978	883,065	1,924,170
Market Cap Growth	64.72%	-24.75%	-30.29%	-32.17%	-54.11%	109.52%
Enterprise Value	391,937	280,401	368,683	519,044	826,852	1,868,498
Last Close Price	5360.00	4109.78	5461.80	7834.55	11550.36	24970.20
PE Ratio	41.05	-	-	-	-	-
Forward PE	-	58.75	58.75	58.75	58.75	58.75
PS Ratio	2.87	1.96	3.32	3.14	4.84	11.34
PB Ratio	1.55	1.29	1.78	2.20	3.15	7.10
P/TBV Ratio	1.59	1.32	1.93	2.34	3.36	7.65
P/FCF Ratio	31.13	9.69	-	49.25	34.31	-
P/OCF Ratio	23.44	9.14	-	36.39	33.29	2660.75
EV/Sales Ratio	2.13	1.75	2.93	2.72	4.53	11.01
EV/EBITDA Ratio	30.40	48.99	-	106.23	79.01	183.44
EV/EBIT Ratio	51.10	173.34	-	-	147.08	463.86
EV/FCF Ratio	23.07	8.65	-	42.67	32.12	-
Debt / Equity Ratio	0.24	0.33	0.34	0.00	0.01	0.08
Debt / EBITDA Ratio	6.09	13.88	-	0.19	0.15	2.12
Debt / FCF Ratio	4.72	2.45	-	0.08	0.06	-
Net Debt / Equity Ratio	-0.40	-0.21	-0.31	-0.31	-0.29	-0.25
Net Debt / EBITDA Ratio	-10.41	-8.85	2.16	-17.31	-7.90	-6.68
Net Debt / FCF Ratio	-8.08	-1.56	5.89	-6.95	-3.21	56.98
Asset Turnover	0.45	0.40	0.30	0.48	0.46	0.43
Inventory Turnover	2.10	1.75	1.66	2.87	2.36	2.06
Quick Ratio	3.71	4.37	1.93	3.90	4.79	3.16
Current Ratio	4.60	5.76	2.61	4.90	5.95	4.06
Return on Equity (ROE)	3.36%	-1.45%	-13.60%	-1.54%	-1.01%	-3.38%
Return on Assets (ROA)	1.21%	0.25%	-5.65%	-0.04%	0.88%	0.64%
Return on Invested Capital (ROIC)	4.03%	0.91%	-21.45%	-0.12%	-2.07%	1.63%
Return on Capital Employed (ROCE)	2.00%	0.50%	-11.30%	-0.10%	1.60%	1.20%
Earnings Yield	1.84%	-0.84%	-7.50%	-0.41%	-0.10%	-0.37%
FCF Yield	3.21%	10.32%	-2.92%	2.03%	2.92%	-0.06%
Buyback Yield / Dilution	-9.11%	-	-	0.01%	0.25%	4.24%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.